Gauging joint inflammation via a computer monitor isn't ideal as these are determinations are best done in person, but due to the COVID-19 pandemic, the American College of Rheumatology is encouraging rheumatologists to embrace the technology as physicians increasinly limit the number of in-office visits and as patiets with autoimmune rheumatic disorders increasinly self-isoloate.
Patients with systemic lupus erythematosus depend on hydroxychloroquine to control disease activity, but demand for this drug, which was already in short supply, has spiked since President Trump championed its use for COVID-19 patients. The American College of Rheumatology has responded by issuing a series of recommendations. Learn more in this article.
The American College of Rheumatology recommends treating rheumatoid arthritis early in order to increase the chances of achieving and sustaining remission. Take our clinical quiz to learn more.
Colchicine, a first-line treatment option for acute gout, is associated with an increased risk of adverse events, such as diarrhea and other gastrointestinal symptoms, but not serious adverse events, finds a newly published systematic review and meta-analysis.
The use of abatacept did not lead to significant improvements in the disease status of patients with primary Sjögren's syndrome and in fact, it was essentially no better than placebo treatment, shows the first randomized, double-blind trial on abatacept for Sjögren’s.
Despite the publication of previous clinical trials that showed plasma exchange could possibly be a viable treatment for patients with severe ANCA-associated vasculitis, a new study recently published in the New England Journal of Medicine shows the treatment, in combination with standard therapy, didn't improve outcomes for patients or lower fatality rates or slow the progression to end-stage kidney disease.
On Tuesday, the World Health Organization announced it is recommending that people with COVID-19 symptoms avoid taking the anti-inflammatory drug ibuprofen. U.S. officials and physicians responded with skepticism and today, WHO reversed its decision.
Dr. Philip Robinson, a rheumatologist in Brisbane, Australia, is in the process of creating an international registry that will include information about COVID-19 specifically for patients with rheumatic disease, in particular, those receiving immunosuppressive therapies.
As coronavirus moves its way across the country, Dr. Kim Gorgens, a psychologist with more than 20 years of experience, recommends that rheumatologists proactively reach out to their patients to address concerns that may lead to stress and ill-advised changes in treatment regimens, such as stopping treatments without consulting a physician.
A new study published in the February 5 issue of Annals of the Rheumatic Diseases finds that allopurinol and febuxostat are associated with about the same risk of hypersensitivity reactions, as compared to gout patients treated with colchicine. The risk is even higher for women and diabetes patients, the authors wrote.
March is Women's History Month and in today's issue of the column Awkward Conversations, Dr. Kim Gorgens and Sophia Barnes focus on challenges women in science face. They also offer some key resources you may want on your radar.
To celebrate Women’s History Month, we’re featuring important female figures in rheumatology. In this Q&A with Silvia Ross, M.D., F.A.C.R., managing partner of Triangle Arthritis & Rheumatology Associates, Raleigh, North Carolina, and co-chair of Global Affairs for the Association of Women in Rheumatology, we focus on her work history, her accomplishments, and her future.
The risk of dying from a cardiovascular event can increase by 50 percent for rheumatoid arthritis patients with low serum folate levels, report researchers in JAMA Open Network.
Early rheumatoid arthritis is, in part, defined as having symptoms for at least six months. Beyond six months, it's considered established rheumatoid arthritis. But diagnosing early rheumatoid arthritis is not that straightforward. Serologic tests can confirm a clinical diagnosis, but these tests aren't always reliable and can be negative in about 50 percent of rheumatoid arthritis cases. In this quiz, we focus on the diagnosis and treatment of early rheumatiod arthritis.
The U.S. Food and Drug Administration has approved the first-ever treatment for chronic fibrosing interstitial lung disease (ILD), a condition that can affect rheumatoid arthritis patients. The treatment is designed for patients with a form of the disease that progressively worsens over time.